Copy of newspaper publication dated 06.11.2025 (both hindi and english) regarding un-audited financial results for the quarter/half year ended 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunil Healthcare Ltd has submitted to BSE the newspaper clippings of its un-audited financial results for the second quarter and first half year of FY26 (ended 30 September 2025), published in 'Pioneer' (Hindi and English editions) on 6 November 2025, as required under SEBI Listing Regulations. On a standalone basis, quarterly revenue from operations rose to Rs 2,372.78 lakhs (vs Rs 2,045.10 lakhs in Q2 FY25), with profit after tax jumping to Rs 78.90 lakhs (vs Rs 28.62 lakhs) and EPS of Rs 0.77 (vs Rs 0.04). However, the half-year standalone picture was weak — H1 FY26 PAT was just Rs 3.24 lakhs versus Rs 107.52 lakhs in H1 FY25, indicating that Q1 FY26 was very soft. The company had reported a full-year FY25 loss of Rs 54.83 lakhs. Consolidated H1 FY26 revenue was Rs 4,743.83 lakhs vs Rs 4,207.11 lakhs in H1 FY25, with PAT of Rs 90.78 lakhs vs Rs 190.47 lakhs. Results were approved by the Board on 4 November 2025.
The headline Q2 profit rebound is positive, but the sharp H1 FY26 standalone profit drop and the FY25 loss highlight ongoing volatility in earnings. Shareholders should expect continued pressure on profitability metrics in the near term, with the stock likely to react cautiously until a clearer recovery trend in subsequent quarters emerges.